These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18849563)

  • 21. [Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV₁/FEV₆ for the diagnosis of COPD].
    Miravitlles M; Llor C; Calvo E; Diaz S; Díaz-Cuervo H; Gonzalez-Rojas N
    Med Clin (Barc); 2012 Nov; 139(12):522-30. PubMed ID: 22015009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
    Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
    Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of lung mitochondrial prohibitin in COPD.
    Soulitzis N; Neofytou E; Psarrou M; Anagnostis A; Tavernarakis N; Siafakas N; Tzortzaki EG
    Respir Med; 2012 Jul; 106(7):954-61. PubMed ID: 22521224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease.
    Radom-Aizik S; Kaminski N; Hayek S; Halkin H; Cooper DM; Ben-Dov I
    J Appl Physiol (1985); 2007 May; 102(5):1976-84. PubMed ID: 17483440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical phenotypes of COPD: results of a Japanese epidemiological survey.
    Tatsumi K; Kasahara Y; Kurosu K; Tanabe N; Takiguchi Y; Kuriyama T;
    Respirology; 2004 Aug; 9(3):331-6. PubMed ID: 15363004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Epicardial Adipose Tissue Is Associated with the Airway Dominant Phenotype of Chronic Obstructive Pulmonary Disease.
    Higami Y; Ogawa E; Ryujin Y; Goto K; Seto R; Wada H; Tho NV; Lan le TT; Paré PD; Nakano Y
    PLoS One; 2016; 11(2):e0148794. PubMed ID: 26866482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of β-catenin in human pulmonary tissues of smokers with and without chronic obstructive pulmonary disease].
    Liu QX; Liu XS; Ni W; Chen SX; Xu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Nov; 35(11):828-32. PubMed ID: 23290038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Array of hope: expression profiling identifies disease biomarkers and mechanism.
    Bhattacharya S; Mariani TJ
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):855-62. PubMed ID: 19614607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood gene expression profiles in COPD subjects.
    Bhattacharya S; Tyagi S; Srisuma S; Demeo DL; Shapiro SD; Bueno R; Silverman EK; Reilly JJ; Mariani TJ
    J Clin Bioinforma; 2011 Apr; 1(1):12. PubMed ID: 21884629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.
    Xie L; Wu M; Lin H; Liu C; Yang H; Zhan J; Sun S
    Mol Biosyst; 2014 May; 10(5):1072-81. PubMed ID: 24556821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of exhaled particles from the human lungs in airway obstruction.
    Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.
    Boelens MC; Gustafson AM; Postma DS; Kok K; van der Vries G; van der Vlies P; Spira A; Lenburg ME; Geerlings M; Sietsma H; Timens W; van den Berg A; Groen HJ
    Lung Cancer; 2011 May; 72(2):177-83. PubMed ID: 20832896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
    He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers in chronic obstructive pulmonary disease: confusing or useful?
    Stockley RA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():163-77. PubMed ID: 24532968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
    Hollander Z; DeMarco ML; Sadatsafavi M; McManus BM; Ng RT; Sin DD
    Chest; 2017 Feb; 151(2):455-467. PubMed ID: 27693595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.